Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
This report contains market size and forecasts of Chorea Treatment in Global, including the following market information:
Global Chorea Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chorea Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chorea Treatment include Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova and Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chorea Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chorea Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chorea Treatment Market Segment Percentages, by Type, 2021 (%)
Medication
Surgery Therapy
Global Chorea Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chorea Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Chorea Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chorea Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chorea Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chorea Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech